Southeast Bone Marrow Transplant and Cell Therapy Network
BMT Core: Southeast Bone Marrow Transplant Consortium
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11168784
This network runs clinical trials of bone marrow and cell therapies for people with blood cancers, sickle cell and other marrow disorders in the Southeastern U.S.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11168784 on ClinicalTrials.gov |
What this research studies
If you or a family member need a bone marrow transplant or cell-based therapy, this network runs phase 2 and 3 trials at four Southeastern medical centers. The trials use hematopoietic stem cell transplants and adoptive cell therapies (including CAR‑T approaches) and collect blood and tissue samples for research. The consortium focuses on enrolling a diverse mix of patients from the Southeast, including rural communities and pediatric patients. Care and study follow-up take place at participating sites (Emory, University of Florida, UAB, and University of Miami) and samples and data are shared with a central biorepository to support future science.
Who could benefit from this research
Good fit: People in the Southeastern U.S. who have conditions that may be treated with stem cell transplant or adoptive cell therapy (for example certain blood cancers, sickle cell disease, or marrow failure) and who meet trial-specific eligibility criteria.
Not a fit: People without transplant-eligible blood or marrow conditions, those who live far from consortium sites and cannot travel, or those who do not meet trial eligibility (age, organ function, prior treatments) are unlikely to benefit.
Why it matters
Potential benefit: Could expand access to newer bone marrow and cell-based treatments and improve outcomes for people with blood cancers, hemoglobinopathies, and marrow failure.
How similar studies have performed: Bone marrow transplants and CAR‑T/adoptive cell therapies have helped many patients with blood cancers, and this consortium builds on that established success while expanding access and testing new approaches.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WALLER, EDMUND K — EMORY UNIVERSITY
- Study coordinator: WALLER, EDMUND K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.